Share of adolescent girls vaccinated against human papillomavirus in United States of America
United States of America: Share of adolescent girls vaccinated against human papillomavirus was 65.0% in 2024. ▲ Rising
Share of adolescent girls vaccinated against human papillomavirus in United States of America, 2010–2024
Source: WHO & UNICEF (2025) – processed by Our World in Data. Measured in %.
Analysis
United States of America recorded 65.0% for share of adolescent girls vaccinated against human papillomavirus in 2024.
The figure is up 58.5% over ten years.
Over the whole period, share of adolescent girls vaccinated against human papillomavirus in United States of America peaked at 69.0% in 2021 and was at its lowest, 32.0%, in 2010.
That places United States of America 38th out of 74 countries with data for 2024, putting it in the middle of the range.
The long-run direction has been consistently rising across the 15 years of available data.
Share of adolescent girls vaccinated against human papillomavirus in United States of America, year by year
| Year | % | Change |
|---|---|---|
| 2010 | 32.0% | — |
| 2011 | 38.0% | +18.8% |
| 2012 | 35.0% | -7.9% |
| 2013 | 39.0% | +11.4% |
| 2014 | 41.0% | +5.1% |
| 2015 | 44.0% | +7.3% |
| 2016 | 52.0% | +18.2% |
| 2017 | 53.0% | +1.9% |
| 2018 | 55.0% | +3.8% |
| 2019 | 62.0% | +12.7% |
| 2020 | 64.0% | +3.2% |
| 2021 | 69.0% | +7.8% |
| 2022 | 68.0% | -1.4% |
| 2023 | 65.0% | -4.4% |
| 2024 | 65.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 45.1% | 32.0% | 62.0% | 10 |
| 2020s | 66.2% | 64.0% | 69.0% | 5 |
Countries ranked near United States of America
More health data for United States of America
- Un projection of annual infant deaths, annual growth rate -1.67 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.1867 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,069 deaths per 1,000 people (2090)
- Number of infants who die before age 1 4,015 deaths (2100)
- Population ages 60-64, female, annual growth rate -0.7632 % change on previous year (2025)
- Population ages 60-64, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 60-64, female, per capita 0.0312 units per person (2025)
- Population ages 60-64, male, annual growth rate -0.6788 % change on previous year (2025)
- Population ages 60-64, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 60-64, male, per capita 0.0308 units per person (2025)
Frequently asked questions
- What is share of adolescent girls vaccinated against human papillomavirus in United States of America?
- Share of adolescent girls vaccinated against human papillomavirus in United States of America was 65.0% in 2024, according to WHO & UNICEF (2025) – processed by Our World in Data.
- What is the highest share of adolescent girls vaccinated against human papillomavirus recorded in United States of America?
- The highest recorded value was 69.0% in 2021.
- What is the lowest share of adolescent girls vaccinated against human papillomavirus recorded in United States of America?
- The lowest recorded value was 32.0% in 2010.
- How does United States of America rank for share of adolescent girls vaccinated against human papillomavirus?
- United States of America ranks 38th out of 74 countries with data for 2024.
- Is share of adolescent girls vaccinated against human papillomavirus rising or falling in United States of America?
- Over the last ten years it is up 58.5%. The long-run trend across the full record is rising.
- Where does this United States of America data come from?
- The figures come from WHO & UNICEF (2025) – processed by Our World in Data, published as part of Share of adolescent girls vaccinated against human papillomavirus. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 15 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Share of fifteen-year-old girls who, between the ages of 9 and 14, received their last dose of the human papillomavirus vaccine.